Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
251.00
+12.00 (5.02%)
Apr 14, 2026, 7:45 AM KST
-97.59%
Market Cap 49.59B
Revenue (ttm) 73.23B
Net Income (ttm) -170.33B
Shares Out 13.17M
EPS (ttm) -12,930.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,798,942
Average Volume 599,527
Open 250.00
Previous Close 239.00
Day's Range 240.00 - 258.00
52-Week Range 251.00 - 11,220.00
Beta -0.09
RSI 14.94
Earnings Date May 13, 2026

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1960
Employees 391
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2025, Aprogen Biologics's revenue was 73.23 billion, an increase of 8.68% compared to the previous year's 67.38 billion. Losses were -170.33 billion, 62.3% more than in 2024.

Financial Statements

News

There is no news available yet.